We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Diffusion Weighted MRI for Lymphnodes in the Axilla

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00276211
Recruitment Status : Completed
First Posted : January 13, 2006
Last Update Posted : January 28, 2009
Information provided by:

Study Description
Brief Summary:
This study is going to compare diffusionweigthed MRI scanning to the result of surgey in patients with metastasis from brestcancer in the axilla

Condition or disease
Breast Cancer

Study Design

Study Type : Observational
Estimated Enrollment : 10 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diffusionsvægtet MR Skanning Med Henblik på axillære Lymfeknudemetastaser Hos Patienter Med primær Mammacancer - et Pilotstudie
Study Start Date : January 2006
Study Completion Date : December 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Newly diagnosed breast cancer patients, where ultrasound and cytologi has proved one or more malignant lymphnodes in the axilla.

Exclusion Criteria:

Pacemaker metal in the body claustrphobia psychiatry patients pregnancy age below 18 years

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00276211

Department of Radiology, Herlev University Hospital
Herlev, Denmark, DK 2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Principal Investigator: Jakob M Møller, M.Sc. Copenhagen University Hospital at Herlev
More Information

Responsible Party: Copenhagen University Hospital at Herlev, Region H
ClinicalTrials.gov Identifier: NCT00276211     History of Changes
Other Study ID Numbers: KA-20051023
First Posted: January 13, 2006    Key Record Dates
Last Update Posted: January 28, 2009
Last Verified: January 2006

Keywords provided by Copenhagen University Hospital at Herlev:
MRI diffusion mamma cancer